1. Home
  2. IRWD vs VREX Comparison

IRWD vs VREX Comparison

Compare IRWD & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.44

Market Cap

526.7M

Sector

Health Care

ML Signal

HOLD

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$11.97

Market Cap

580.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRWD
VREX
Founded
1998
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
526.7M
580.6M
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
IRWD
VREX
Price
$4.44
$11.97
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$7.67
$16.67
AVG Volume (30 Days)
1.8M
202.1K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
1400.00
N/A
EPS
0.15
0.05
Revenue
$298,276,000.00
$811,000,000.00
Revenue This Year
$57.95
$5.35
Revenue Next Year
$4.39
$3.88
P/E Ratio
$28.87
$232.40
Revenue Growth
8.88
N/A
52 Week Low
$0.55
$6.76
52 Week High
$5.78
$14.57

Technical Indicators

Market Signals
Indicator
IRWD
VREX
Relative Strength Index (RSI) 67.36 61.43
Support Level $3.07 $11.43
Resistance Level $5.67 $12.61
Average True Range (ATR) 0.23 0.35
MACD 0.14 0.22
Stochastic Oscillator 95.52 89.06

Price Performance

Historical Comparison
IRWD
VREX

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

Share on Social Networks: